1Guler S, Cakir B, Demirbas B, et al. Plasma soluble intercellular adhesion molecule-1 levels are increased in type 2 diabetic patients with nephropathy[J]. Horm Res,2002,58:67-70.
2Sugimoto A, Kenichi S, Kycji H, et al. Increased expression of intercellular adhesion molecule-1 in diabetic rat glomeruli [J].Diabetes, 1997,46: 2075
4Clausen P, Jacobsen P, Rossing K, et al. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with type 1diabetes mellitus with microalbuminuria and overt nephropathy[J]. Diabet Med,2000,17(9) :644-649.
5Roffaele M, Kathring E, Rriccardo G, et al. Circulation adhesion molecules in humans role of hyperglycemia and hyperinsulinemia[J]. Circulation, 2000,101: 2247-2255.
6Targher G, Bonadonna RC, Alberiche M, et al. Relation between soluble adbesion molecules and insulin sensitivity in type 2diabetes individuals:role of adipose tissur [J]. Diabetes Care,2001,24:1961-1966.
7Cnaier W F, Simeceh S, Kukovetz W R, et al. High D-glucose induced change in endothelial Ca/EDRF signaling is due to generation of superoxideanions [ J ]. Diabetes, 1996,45:1386-1395.
2Kim I, Moon SO, Kim SH, et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1(ICAM-1), vascular cell adhesion molecule 1 (VCAM-1),and E-selectin through nuclear factor-kappa B activation in endothelial cells [J]. J Biol Chem, 2001,276(10) : 7614 -7620.
3Gilbert RE, Vranes D, Berka JL, et al. Vascular endothelial growth factor and its receptors in control and diabetic rats eyes [J]. Lab Invest, 1998, 78(8) : 1017- 1027.
4Clausen P, Jacobsen P, Rossing K, et al. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with type 1 diabetes mellitus with microalbuminuria and overt nephropathy [J]. Diabet Med, .2030, 17(9): 644-649.
5Vriese AS, Tilton RG, Elger II, et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes [ J ]. J Am Soc Nephrol,2001, 12(5) : 993 - 1 000.
6Amemiya T, Sasamura H, Mifune M, et al. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells [ J]. Kidney Int,1999, 56(6) : 2055 - 2063.
7Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors [J]. FASEBJ, 1999, 13(1): 9-22.
2Kamiuchi K,Hasegawa G,Obayashi H,et al.Leukocyte-endothelial cell adhesion molecule 1(LECAM-1)polymorphism is associated with diabetic nephropathy in Type 2 diabetes mellitus[J].J Diabetes Complications,2002,16(5):333-337.
3Butcher EC.Leukocyte-endothelial cell recognition:three(or more)steps to specificity and diversity[J].Cell,1991,67(6):1033-1036.
4Maruya E,Saji H,Seki S,et al.Evidence that CD31,CD49b and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants[J].Blood,1998,92:2169-2176.
5Hirata K,Shikata K,Matsμda M,et al.Increased expression of selection in kidneys of patients with diabetic nephropathy[J].Diabetologia,1998,41:185-192.
6Ina K,Kitamura H,Okedam T,et al.Vasscular cell adhesion molecule-1 exprssion in the renal interstitium of diabetic KKAy mice Diabetes[J].Research and Clinical Practice,1999,44:1-8.
7Clausen P,Jcobsen P,Rossing J,et al.Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy[J].Diabetes Medicine,2000,17:644-649.
8Xavier Pi-Sunyer.The Metabolic Syndrome:How to approach differing definitions[J].Obesity Management,2006,27:58-62
9American Diabetes Association.Diagnosis and classification of diabetes mellitus[J].Diabetes Care,2006,29(Suppl1):S43-48
10International Diabetes Federation.The IDF consensus worldwide definition of the metabolic syndrome.Part 1:Worldwide definition for use in clinical practice[R].IDF,2005
